In mixed lineage leukemia (MLL)-fusion leukemia, menin acts as a tumor promoter by serving as a scaffold to recruit MLL-fusion proteins and facilitate their histone H3 lysine 4 (H3K4) methylation, which subsequently drives leukemogenesis [4]. Here, KMT2A is linked to neoplasm.